MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$9,094K
Net loss
-$161,307K
Total other income,
net
$8,520K
Interest expense
$489K
Other expense, net
-$85K
Loss from operations
-$169,827K
Total operating
expenses
$169,827K
Research and development
$133,720K
General and
administrative
$36,107K
Back
Back
Income Statement
source: myfinsight.com
Kyverna Therapeutics, Inc. (KYTX)
Kyverna Therapeutics, Inc. (KYTX)